RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...

The company, founded in 2022, last year raised $52 million in a Series A funding round led by investors Eight Roads and 3E Bioventures.

The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...

पार्किंसन डिजीज एक न्यूरोलॉजिकल बीमारी है. अब इसकी पहचान और इलाज में बड़ा बदलाव आने वाला है. हाल ही में Nature Aging में छपी ...

Partly focused on delivery challenges that have limited the reach of RNA medicines, new biotech company Axelyf Inc. closed a $2.6 million seed round to support development of its AXL technology and to ...

RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...

AI-driven discovery aims to speed development, improve delivery precision, and expand therapeutic potential of Circurna’s ciRNA™ circular RNA platformHOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE ...

DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...

Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...